These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. [Comparative evaluation of the effectiveness and safety of combined drug therapy of patients with benign prostatic hyperplasia with finasteride and alfuzozine]. Loran OB; Pushkar' DIu; Rasner PI Urologiia; 2002; (1):19-22. PubMed ID: 11877966 [TBL] [Abstract][Full Text] [Related]
11. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group. McConnell JD; Bruskewitz R; Walsh P; Andriole G; Lieber M; Holtgrewe HL; Albertsen P; Roehrborn CG; Nickel JC; Wang DZ; Taylor AM; Waldstreicher J N Engl J Med; 1998 Feb; 338(9):557-63. PubMed ID: 9475762 [TBL] [Abstract][Full Text] [Related]
12. Benign prostatic hyperplasia: natural history, endocrine pathogenesis, and medical treatment with finasteride. Sherwood LM Mt Sinai J Med; 1996 Jan; 63(1):1-9. PubMed ID: 8935843 [No Abstract] [Full Text] [Related]
13. Finasteride: a steroid-unsparing drug? Persey M; Payne L; Webley M Rheumatology (Oxford); 1999 Mar; 38(3):285. PubMed ID: 10325672 [No Abstract] [Full Text] [Related]
14. [Efficacy and safety of doxazosine in combination with finasteride in the treatment of prostatic adenoma]. Bogdanov AB; Luk'ianov IV; Veliev EI Urologiia; 2008; (6):44-9. PubMed ID: 19248599 [TBL] [Abstract][Full Text] [Related]
15. Urticarial rush due to finasteride. Moreno-Fernandez A; Mira Laguarda JM; Ruiz-Hornillos FJ; Rubio Sotes M Allergy; 2010 Mar; 65(3):405-6. PubMed ID: 19814757 [No Abstract] [Full Text] [Related]